Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
06/07/2001 | WO2001039767A1 Tertiary amino compounds having opioid receptor affinity |
06/07/2001 | WO2001039766A2 Screening invertebrate pheromones for therapeutic activity |
06/07/2001 | WO2001039747A2 Cassette-shaped constructional units in a rotary printing machine |
06/07/2001 | WO2001039742A2 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
06/07/2001 | WO2001039723A2 Triazospiro compounds having nociceptin receptor affinity |
06/07/2001 | WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
06/07/2001 | WO2001028557B1 Cannabimimetic indole derivatives |
06/07/2001 | WO2001015553B1 Dietary food supplement containing natural cyclooxygenase inhibitors |
06/07/2001 | WO2001007612A3 Receptors and associated proteins |
06/07/2001 | WO2000074703B1 Therapeutic agent comprising a botulinum neurotoxin |
06/07/2001 | WO2000069424A3 Method of treating psychotic disorders |
06/07/2001 | US20010002999 For oral administration comprising an analgesic with rapid onset of action and at least one systemically acting analgesic with sustained action, such as a combination of benzocaine and acetylsalicylic acid (ASA) |
06/07/2001 | US20010002998 Over-coated chewing gum formulations including tableted center |
06/07/2001 | DE19958684A1 Verwendung von GD3-Synthase-Inhibitoren zur Behandlung neuropathologischer Störungen und Verfahren zur Identifizierung von GD3-Synthase-Inhibitoren Use of GD3 synthase inhibitors for the treatment of neuropathological disorders, and to methods for identifying the GD3 synthase inhibitors |
06/07/2001 | DE19958388A1 Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten Triazinone compounds for the treatment of diseases caused by infestation with parasitic protozoa |
06/07/2001 | DE19952146A1 Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Arylalkanes, aryl alkenes and aryl azaalkane, pharmaceutical compositions containing them and methods for their preparation |
06/07/2001 | DE19948434A1 Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine Substance library containing bicyclic imidazo-5-amines and / or bicyclic imidazo-3-amine |
06/07/2001 | DE19910986C2 Verwendung von Xenon bei der Behandlung von Neurointoxikationen Use of xenon in the treatment of Neurointoxikationen |
06/07/2001 | CA2393179A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
06/07/2001 | CA2393115A1 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
06/07/2001 | CA2392993A1 Agent for improving learning and/or memory |
06/07/2001 | CA2392991A1 Semaphorin receptor |
06/07/2001 | CA2392948A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
06/07/2001 | CA2392931A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
06/07/2001 | CA2392929A1 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same |
06/07/2001 | CA2392810A1 A rapid acting freeze dired oral pharmaceutical composition for treating migraine |
06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
06/07/2001 | CA2392693A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
06/07/2001 | CA2389368A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
06/07/2001 | CA2388559A1 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
06/07/2001 | CA2388239A1 Neuroprotective agents and methods related thereto |
06/07/2001 | CA2327575A1 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
06/06/2001 | EP1104760A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
06/06/2001 | EP1104759A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |
06/06/2001 | EP1104464A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
06/06/2001 | EP1104446A1 Biologically active fraction of vegetable melanin, process for its production and its use |
06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
06/06/2001 | EP1104421A1 3-(4-amino-5-ethylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1h-pyrazolo 3,4-b]pyridine |
06/06/2001 | EP1104420A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
06/06/2001 | EP1104419A1 N-substituted azabicycloheptane derivatives, production and use thereof |
06/06/2001 | EP1104413A2 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them |
06/06/2001 | EP1104412A1 Tace inhibitors |
06/06/2001 | EP1104408A2 Drug targeting |
06/06/2001 | EP1104404A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
06/06/2001 | EP1104403A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
06/06/2001 | EP1104402A1 Pipecolic acid derivatives and their use for vision and memory disorders |
06/06/2001 | EP1104301A1 Method of treatment |
06/06/2001 | EP0889891B1 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity |
06/06/2001 | EP0873329B1 Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands |
06/06/2001 | EP0802914B1 Aryl- and heteroaryl- purine and pyridopyrimidine derivatives |
06/06/2001 | EP0777659B1 Morpholine derivatives and their use as therapeutic agents |
06/06/2001 | EP0676961B1 Use of macrolides for the treatment of cerebral ischemia |
06/06/2001 | CN1298394A Aryl fused azapolycyclic compounds |
06/06/2001 | CN1298393A Quinoline derivatives |
06/06/2001 | CN1298386A N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders |
06/06/2001 | CN1298383A Process for the preparation of tetralone imines for the preparation of active pharmaceutical compounds |
06/06/2001 | CN1298309A Method for treating painful conditions of the anal region and compositions therefor |
06/06/2001 | CN1298301A Treatment of generalized anxiety disorder with paroxetine |
06/06/2001 | CN1298294A Nicotine inhaler |
06/06/2001 | CN1297888A 2-(3,5-=-trifluoromethyl-phenyl)-N methyl-N-(6-morpholine-4-radical-4-o-tolyl-pyridine-3-radical)-isobutyryl |
06/06/2001 | CN1297887A Process for producing pyridine derivate |
06/06/2001 | CN1297753A Kelp product used as tranquilizer and soporific or health tonic and its preparation |
06/06/2001 | CN1297740A Compound medicine for migraine |
06/06/2001 | CN1297737A Preparation of medicine for restoring the normal transmitting function of nerve |
06/06/2001 | CN1066734C Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
06/06/2001 | CN1066733C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
06/06/2001 | CN1066727C Anti-migraine indole derivative salts |
06/06/2001 | CN1066726C 吡咯衍生物 Azole derivatives |
06/06/2001 | CN1066720C Process for producing pharmaceutically active CNS compounds |
06/06/2001 | CN1066719C Process for producing pharmaceutically active CNS compounds |
06/06/2001 | CN1066718C Substituted aryloxy-alkyl diamines and its producing process and use |
06/06/2001 | CN1066625C Therapeutical use for benzopyran derivative |
06/06/2001 | CN1066624C Dry mix formulation for bisphosphonic acids |
06/06/2001 | CA2328553A1 Novel derivatives (dihydro)benzoxazine and (dihydro)benzothiazine substitutes, process for preparing them and pharmaceutical compositions containing them |
06/05/2001 | US6242637 Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present |
06/05/2001 | US6242619 19-norpregnane steroids as neurochemical initiators of change in human hypothalamic function |
06/05/2001 | US6242601 Heterocyclic sulfamides |
06/05/2001 | US6242578 Glycoconjugate of carbohydrate covalently bound to peptide of defined amino acid sequence; prevention of influenza virus binding to cells, treatment of schizophrenia, and diagnosis of chronic viral diseases related to cancer |
06/05/2001 | US6242488 Method for preventing and treating pain |
06/05/2001 | US6242479 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
06/05/2001 | US6242473 Administering histamine |
06/05/2001 | US6242468 Carbamate and urea compositions and neurotrophic uses |
06/05/2001 | US6242462 Novel decahydroisoquinoline derivatives which are selective glur5 receptor antagonists. |
06/05/2001 | US6242460 Zolpidem salt forms |
06/05/2001 | US6242438 3-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
06/05/2001 | US6242416 Inhibition of β-amyloid binding to the p75 nerve growth factor receptor |
06/05/2001 | US6242386 Drugs formed by hydrolysis of camphor in the presence of metallorganic compounds and basic salts |
06/05/2001 | US6242002 Rapidly disintegrating oral dosage form of alkali-sensitive material, effervescent base of alkaline earth metal carbonate, organic edible acid and alkali metal salt of citric acid, auxiliary ingredients |
06/05/2001 | US6242000 Analgesic, antiinflammatory agent |
06/05/2001 | US6241988 Stable extract of hypericum perforatum L., a method for producing the same, and corresponding pharmaceutical preparations |
06/05/2001 | US6241981 Composition and method for repairing neurological tissue |
06/05/2001 | US6241976 With continuous phase containg water-immiscible liquid carrier and gel-forming structurant, disperse phase which is solution of antiperspirant active in water, optional solvent |
06/04/2001 | WO2001042474A2 Interferon-like molecules and uses thereof |
06/04/2001 | CA2395408A1 Interferon-like molecules and uses thereof |
06/03/2001 | CA2327385A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
06/03/2001 | CA2327256A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |